Tag: I3

Intravascular Imaging Incorporated (“i3”) Announces Launch of Its 3-French NIRF-IVUS Imaging Catheter Intended for Human Coronary Imaging, with Favorable Tests in Ex-Vivo Human Coronaries, and Launch of Series A Financing

Molecular and Pathophysiologic Imaging of Coronary Disease, Dissections and Unhealed Stents Expands Therapeutic Options by Combining Intravascular Ultrasound (IVUS) and Near-Infrared Fluorescence (NIRF) Imaging. BOSTON, and WILTON, Conn., July 18, 2022 /PRNewswire/ — I3 today announced the launch of its proprietary 3-French NIRF-IVUS Catheter designed in collaboration with the Massachusetts General Hospital. The device […]